Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Amyotrophic Lateral Sclerosis (Phase 1/Phase 2)
Anterior Wall Myocardial Infarction (Phase 3)
Cardiomyopathies (Phase 2)
Cardiovascular Diseases (Phase 1/Phase 2)
Coronary Artery Disease (Phase 2)
COVID-19 (Phase 2)
Diabetes Mellitus, Type 1 (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Diabetic Nephropathies (Phase 1/Phase 2)
Erectile Dysfunction (Phase 1/Phase 2)
Fractures, Bone (Phase 2)
Heart Failure (Phase 3)
Inflammatory Bowel Diseases (Phase 1/Phase 2)
Knee Injuries (Phase 2)
Mesenchymal Stem Cell Transplantation (Phase 1/Phase 2)
Myocardial Infarction (Phase 3)
Osteoarthritis (Phase 2)
Osteoarthritis, Hip (Phase 1/Phase 2)
Osteoarthritis, Knee (Phase 2)
Osteoporotic Fractures (Phase 2)
Poisoning (Phase 3)
Regenerative Medicine (Phase 3)
Respiratory Distress Syndrome (Phase 2)
Retinal Diseases (Phase 3)
Retinitis Pigmentosa (Phase 3)
SARS-CoV-2 (Phase 1/Phase 2)
Spinal Cord Injuries (Phase 2)
ST Elevation Myocardial Infarction (Phase 3)
Stem Cells (Phase 3)
Toxic Optic Neuropathy (Phase 3)
Transcranial Magnetic Stimulation (Phase 3)
Ventricular Remodeling (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
